NEWS: Acquisition "Black-Eyed Dog" Hannover House

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
NEWS: Acquisition "Black-Eyed Dog"




Hannover House Launches Medallion International at Cannes, with Worldwide Rights Acquisition of "Black-Eyed Dog"


CANNES, FRANCE / ACCESSWIRE / May 14, 2014 / Hannover House, Inc. (OTC: HHSE), has officially launched its new international sales and financing company, Medallion International Pictures, at the Cannes Film Festival and Marche du Film today, and has announced the acquisition of worldwide distribution rights to director Erica Dunton's youth-thriller, "Black-Eyed Dog." Other Medallion titles on display at the festival include the upcoming productions of "Mother Goose: Journey to Utopia" and "The Legend of Belle Starr."

"Black-Eyed Dog" is the next film from director Erica Dunton following her Sundance Film Festival Audience Award for "To.Get.Her". This 2014 production presents a coming of age story of four young friends as they struggle with life and death circumstances affecting one of their parents. The cast includes Hilarie Burton ("The Secret Life of Bees" , Paul Schneider ("Parks and Recreation" and Joshua Leonard ("Blair Witch Project" , with outstanding performances delivered by the youth cast of MacKenzie Foy ("Twilight Saga: Breaking Dawn" , Chandler Canterbury ("The Host" and Johnny Sequoyah ("Believe" . Several of the film's producers also possess impressive credits, including Heather Rae ("Frozen River", "Windwalkers" , Stephanie Caleb ("Getaway", "Cake" and Spencer Silna ("Lone Survivor", "The Grey", "Killing Them Softly" . Lead star Mackenzie Foy is also starring in director Christopher Nolan's epic "Interstellar" which opens worldwide this November from Paramount Pictures.

The film is described as having a similar theme and concept to "Stand By Me" and "To Kill A Mockingbird." Other credited producers and executive producers include Betsy Davis, Tomy Drissi, Erica Dunton's, Eric Parkinson, Kevin Lee Allen and Richard Bach.

In addition to selling international rights through Medallion, Hannover House will be releasing "Black-Eyed Dog" to theatres in the U.S. beginning September 26. The initial release in New York, Los Angeles and Chicago will be designed to meet qualifying criteria for the Academy Awards and Golden Globes; the film will be expanded to additional key theatrical markets nationwide prior to its December, 2014 home video and video-on-demand launch in the USA and Canadian markets.

Financing for the acquisition and release of "Black-Eyed Dog" - as well as the financing for the company's market presence at Cannes - has been provided through private, New York based investors for Hannover House. These, and other private investors, will be providing financing for additional Hannover House acquisitions and P&A costs throughout 2014 and 2015.

"We are very excited to be launching Medallion at the Cannes market," said Hannover House President Fred Shefte. "With two major productions on offer for presale, and one completed movie ready for delivery, we can quickly build momentum as a respected, new supplier to the international markets."

Hannover House and Medallion International Pictures can be located at Cannes in the Palais Riviera, G-23, with Odyssey Pictures Corp.

(2 Photos included in Press Release)


http://finance.yahoo.com/news/hannover-house-...00217.html


.

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 257

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 85

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 52

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 110

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

DESRI Completes Major Financing for Texas Solar Projects

Updated Category News Views 324

DESRI Completes Major Financing for Texas Solar Projects Today, DESRI proudly announced that it has closed a significant preferred equity financing of $129 million aimed at a 250-megawatt (MWac) solar development portfolio. This portfolio consists of two innovative solar projects located in West Texas, an area ripe for renewable energy enhancement. Meeting Industrial...

Continue Reading
Colossal Foundation Invests $500,000 in Condor Restoration Efforts

Updated Category News Views 76

Colossal Foundation Invests in Wildlife Recovery The Colossal Foundation has made a significant commitment of $500,000 towards restoring the California condor to its ancestral skies. This incredible movement represents a decade-long partnership with the Nez Perce Tribe, focusing on the recovery and reintroduction of North America’s largest land bird. For more than a...

Continue Reading
Revolutionary Self-Healing Film: The Future of Waterproofing

Updated Category News Views 108

Revolutionary Waterproofing Solutions by Charter Next Generation Charter Next Generation (CNG) recently unveiled its groundbreaking Nail Sealable film technology, designed to transform waterproofing in the construction industry. This pioneering self-healing film stands out with its exceptional moisture resistance and remarkable durability, making it a game changer for...

Continue Reading
Sonnet BioTherapeutics Provides Positive Safety Insights on SON-1010

Updated Category News Views 273

Exciting Safety Data from Sonnet BioTherapeutics’ SON-1010 Trial Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) has unveiled impressive topline safety data following a successful dose escalation of SON-1010 in the Phase 1 SB101 clinical trial. The study focused on the administration of SON-1010 to patients suffering from advanced solid tumors, marking a significant...

Continue Reading
Key Legal Information for Symbotic Inc. Shareholders

Updated Category News Views 73

Important Information for Symbotic Inc. Investors Recent developments surrounding Symbotic Inc. have captured the attention of investors globally. Investors who are shareholders of Symbotic Inc. (NASDAQ: SYM) may need to be aware of significant deadlines regarding a recent securities class action lawsuit. Overview of the Lawsuit Investors are reminded that they may have...

Continue Reading